Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000041817 | SCV000065513 | uncertain significance | not specified | 2011-09-17 | criteria provided, single submitter | clinical testing | Variant classified as Uncertain Significance - Favor Benign. The Arg926His varia nt in USH2A has not been reported in the literature nor previously identified by our laboratory. Computational analyses (biochemical amino acid properties, homo logy, PolyPhen2, SIFT, AlignGVGD) do not provide strong support for or against p athogenicity. In summary, the clinical significance of this variant cannot be de termined with certainty at this time. |
Gene |
RCV001243252 | SCV000523476 | uncertain significance | not provided | 2024-10-01 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 25078356) |
Counsyl | RCV000665768 | SCV000789939 | uncertain significance | Usher syndrome type 2A; Retinitis pigmentosa 39 | 2017-02-27 | criteria provided, single submitter | clinical testing | |
Blueprint Genetics | RCV001074040 | SCV001239608 | uncertain significance | Retinal dystrophy | 2018-11-12 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001243252 | SCV001416398 | uncertain significance | not provided | 2022-10-13 | criteria provided, single submitter | clinical testing | This sequence change replaces arginine, which is basic and polar, with histidine, which is basic and polar, at codon 926 of the USH2A protein (p.Arg926His). This variant is present in population databases (rs146916397, gnomAD 0.02%). This variant has not been reported in the literature in individuals affected with USH2A-related conditions. ClinVar contains an entry for this variant (Variation ID: 48491). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt USH2A protein function. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. |
Genome- |
RCV003450833 | SCV004182400 | uncertain significance | Retinitis pigmentosa 39 | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Genome- |
RCV003450832 | SCV004182401 | uncertain significance | Usher syndrome type 2A | 2023-11-04 | criteria provided, single submitter | clinical testing | |
Dept Of Ophthalmology, |
RCV001074040 | SCV004708030 | uncertain significance | Retinal dystrophy | 2023-10-01 | criteria provided, single submitter | research |